$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection 원문보기

Journal of ginseng research = 高麗人參學會誌, v.40 no.4, 2016년, pp.309 - 314  

Im, Kyungtaek (College of Pharmacy, Chung-Ang University) ,  Kim, Jisu (College of Pharmacy, Chung-Ang University) ,  Min, Hyeyoung (College of Pharmacy, Chung-Ang University)

Abstract AI-Helper 아이콘AI-Helper

Korean Red Ginseng (KRG) is a heat-processed ginseng developed by the repeated steaming and air-drying of fresh ginseng. Compared with fresh ginseng, KRG has been shown to possess greater pharmacological activities and stability because of changes that occur in its chemical constituents during the s...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • In addition, KRG and its purified components have also been shown to possess protective activities against microbial infections [18]. In this review, we summarize the current knowledge on the effects of KRG and its components on infections with human pathogenic viruses and discuss the therapeutic potential of KRG as an antiviral and vaccine adjuvant.
본문요약 정보가 도움이 되었나요?

참고문헌 (94)

  1. 1 Munoz F.M. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis 28 2015 221 224 25918956 

  2. 2 Song X. Chen J. Sakwiwatkul K. Li R. Hu S. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re Int Immunopharmacol 10 2010 351 356 20034596 

  3. 3 Baek S.H. Lee J.G. Park S.Y. Bae O.N. Kim D.H. Park J.H. Pectic polysaccharides from Panax ginseng as the antirotavirus principals in ginseng Biomacromolecules 11 2010 2044 2052 20597500 

  4. 4 Martin A. Lemon S.M. Hepatitis A virus: from discovery to vaccines Hepatology 43 2006 S164 S172 16447259 

  5. 5 Nichol K.L. Lind A. Margolis K.L. Murdoch M. McFadden R. Hauge M. Magnan S. Drake M. The effectiveness of vaccination against influenza in healthy, working adults N Engl J Med 333 1995 889 893 7666874 

  6. 6 Munos M.K. Walker C.L. Black R.E. The effect of rotavirus vaccine on diarrhoea mortality Int J Epidemiol 39 Suppl. 1 2010 i56 i62 20348127 

  7. 7 Porter K. Babiker A. Bhaskaran K. Darbyshire J. Pezzotti P. Walker A.S. Determinants of survival following HIV-1 seroconversion after the introduction of HAART Lancet 362 2003 1267 1274 14575971 

  8. 8 Chin'ombe N. Ruhanya V. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies Pan Afr Med J 20 2015 386 26185576 

  9. 9 Ha S.-J. West E.E. Araki K. Smith K.A. Ahmed R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections Immunol Rev 223 2008 317 333 18613845 

  10. 10 Kiefer D. Pantuso T. Panax ginseng Am Fam Physician 68 2003 1539 1542 14596440 

  11. 11 Park J. Rhee D. Lee Y. Biological activities and chemistry of saponins from Panax ginseng C. A. Meyer Phytochem Rev 4 2005 159 175 

  12. 12 Jang D.-J. Lee M.S. Shin B.-C. Lee Y.-C. Ernst E. Red ginseng for treating erectile dysfunction: a systematic review Br J Clin Pharmacol 66 2008 444 450 18754850 

  13. 13 Kim W.Y. Kim J.M. Han S.B. Lee S.K. Kim N.D. Park M.K. Kim C.K. Park J.H. Steaming of ginseng at high temperature enhances biological activity J Nat Prod 63 2000 1702 1704 11141123 

  14. 14 Kim S.K. Park J.H. Trends in ginseng research in 2010 J Ginseng Res 35 2011 389 398 23717084 

  15. 15 Helms S. Cancer prevention and therapeutics: Panax ginseng Altern Med Rev 9 2004 259 274 15387718 

  16. 16 Kim S. Lee Y. Cho J. Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death Biol Pharm Bull 37 2014 938 946 24882407 

  17. 17 Vuksan V. Sievenpipper J. Jovanovski E. Jenkins A.L. Current clinical evidence for Korean red ginseng in management of diabetes and vascular disease: a Toronto's ginseng clinical testing program J Ginseng Res 34 2010 264 273 

  18. 18 Lim D.S. Bae K.G. Jung I.S. Kim C.H. Yun Y.S. Song J.Y. Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation J Infect 45 2002 32 38 12217729 

  19. 19 Lee J.S. Cho M.K. Hwang H.S. Ko E.J. Lee Y.N. Kwon Y.M. Kim M.C. Kim K.H. Lee Y.T. Jung Y.J. Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses J Interferon Cytokine Res 34 2014 902 914 25051168 

  20. 20 Lee J.S. Lee Y.N. Lee Y.T. Hwang H.S. Kim K.H. Ko E.J. Kim M.C. Kang S.M. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication Nutrients 7 2015 1021 1036 25658239 

  21. 21 Lee J.S. Ko E.J. Hwang H.S. Lee Y.N. Kwon Y.M. Kim M.C. Kang S.M. Antiviral activity of ginseng extract against respiratory syncytial virus infection Int J Mol Med 34 2014 183 190 24756136 

  22. 22 Hendley J.O. Gwaltney J.M. Jr. Mechanisms of transmission of rhinovirus infections Epidemiol Rev 10 1988 243 258 2852117 

  23. 23 Seemungal T. Harper-Owen R. Bhowmik A. Moric I. Sanderson G. Message S. Maccallum P. Meade T.W. Jeffries D.J. Johnston S.L. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1618 1623 11719299 

  24. 24 Jarjour N.N. Gern J.E. Kelly E.A.B. Swenson C.A. Dick C.R. Busse W.W. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils J Allergy Clin Immunol 105 2000 1169 1177 10856152 

  25. 25 Charles C.H. Yelmene M. Luo G.X. Recent advances in rhinovirus therapeutics Curr Drug Targets Infect Disord 4 2004 331 337 15578974 

  26. 26 Song J.H. Choi H.J. Song H.H. Hong E.H. Lee B.R. Oh S.R. Choi K. Yeo S.G. Lee Y.P. Cho S. Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3 J Ginseng Res 38 2014 173 179 25378991 

  27. 27 Neumann G. Noda T. Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus Nature 459 2009 931 939 19525932 

  28. 28 Claas E.C. Osterhaus A.D. van Beek R. De Jong J.C. Rimmelzwaan G.F. Senne D.A. Krauss S. Shortridge K.F. Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus Lancet 351 1998 472 477 9482438 

  29. 29 Lee J.S. Hwang H.S. Ko E.J. Lee Y.N. Kwon Y.M. Kim M.C. Kang S.M. Immunomodulatory activity of red ginseng against influenza A virus infection Nutrients 6 2014 517 529 24473234 

  30. 30 Chan L.Y. Kwok H.H. Chan R.W. Peiris M.J. Mak N.K. Wong R.N. Chan M.C. Yue P.Y. Dual functions of ginsenosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis J Ethnopharmacol 137 2011 1542 1546 21872652 

  31. 31 Yoo D.G. Kim M.C. Park M.K. Song J.M. Quan F.S. Park K.M. Cho Y.K. Kang S.M. Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice J Med Food 15 2012 855 862 22856395 

  32. 32 Park E.H. Yum J. Ku K.B. Kim H.M. Kang Y.M. Kim J.C. Kim J.A. Kang Y.K. Seo S.H. Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus J Ginseng Res 38 2014 40 46 24558309 

  33. 33 Yoo D.G. Kim M.C. Park M.K. Park K.M. Quan F.S. Song J.M. Wee J.J. Wang B.Z. Cho Y.K. Compans R.W. Protective effect of ginseng polysaccharides on influenza viral infection PLoS One 7 2012 e33678 22442708 

  34. 34 Yin S.Y. Kim H.J. A comparative study of the effects of whole red ginseng extract and polysaccharide and saponin fractions on influenza A (H1N1) virus infection Biol Pharm Bull 36 2013 1002 1007 23727921 

  35. 35 Quan F.S. Compans R.W. Cho Y.K. Kang S.M. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection Vaccine 25 2007 272 282 16945454 

  36. 36 Xu M.L. Kim H.J. Choi Y.R. Intake of korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza a virus J Ginseng Res 36 2012 396 402 23717142 

  37. 37 Zagury J.F. Franchini G. Reitz M. Collalti E. Starcich B. Hall L. Fargnoli K. Jagodzinski L. Guo H.G. Laure F. Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1 Proc Natl Acad Sci USA 85 1988 5941 5945 3261862 

  38. 38 Kanki P.J. Travers K.U. Mboup S. Hsieh C.C. Marlink R.G. Gueye-NDiaye A. Siby T. Thior I. Hernandez-Avila M. Sankalé J.L. Slower heterosexual spread of HIV-2 than HIV-1 Lancet 343 1994 943 946 7909009 

  39. 39 Requejo H.I. Worldwide molecular epidemiology of HIV Rev Saude Publica 40 2006 331 345 16583048 

  40. 40 de Silva T.I. Cotten M. Rowland-Jones S.L. HIV-2: the forgotten AIDS virus Trends Microbiol 16 2008 588 595 18964021 

  41. 41 Moore R.D. Chaisson R.E. Natural history of HIV infection in the era of combination antiretroviral therapy AIDS 13 1999 1933 1942 10513653 

  42. 42 Cho Y.K. Sung H. Lee H.J. Joo C.H. Cho G.J. Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed Int Immunopharmacol 1 2001 1295 1305 11460310 

  43. 43 Sung H. Jung Y.S. Cho Y.K. Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients Clin Vaccine Immunol 16 2009 1127 1131 19535541 

  44. 44 Cho Y.K. Lee I.C. Shin Y.O. The effect of Korean red ginseng (KRG), zidovudine (ZDV), and the combination of KRG and ZDV on HIV-infected individuals J Bacteriol Virol 31 1996 353 360 

  45. 45 Kim B.R. Kim J.E. Sung H. Cho Y.K. Long-term follow up of HIV-1-infected Korean haemophiliacs, after infection from a common source of virus Haemophilia 21 2015 e1 11 25545303 

  46. 46 Cho Y.K. Sung H. Ahn S.H. Bae I.G. Woo J.H. Won Y.H. Kim D.G. Kang M.W. Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea J Clin Microbiol 40 2002 1319 1325 11923351 

  47. 47 Sung H. Kang S.M. Lee M.S. Kim T.G. Cho Y.K. Korean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patients Clin Diagn Lab Immunol 12 2005 497 501 15817756 

  48. 48 Cho Y.-K. Sung H. Kim T.K. Lim J.Y. Jung Y.S. Kang S.-M. Korean red ginseng significantly slows CD4 T cell depletion over 10 years in HIV-1 infected patients: association with HLA J Ginseng Res 28 2004 173 182 

  49. 49 Cho Y.K. Kim Y.B. Kim Y.K. Lee H.J. Oh W.I. Sequence analysis of C2-V3 region of human immunodeficiency virus type 1 gp120 and its correlation with clinical significance: the effect of long-term intake of Korean red ginseng on env gene variation J Korean Soc Microbiol 32 1997 611 623 

  50. 50 Das S.R. Jameel S. Biology of the HIV Nef protein Indian J Med Res 121 2005 315 332 15817946 

  51. 51 Cho Y.K. Jung Y.S. Sung H. Frequent gross deletion in the HIV type 1 nef gene in hemophiliacs treated with Korean Red Ginseng: inhibition of detection by highly active antiretroviral therapy AIDS Res Hum Retroviruses 25 2009 419 424 19320564 

  52. 52 Cho Y.K. Lim J.Y. Jung Y.S. Oh S.K. Lee H.J. Sung H. High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng Curr HIV Res 4 2006 447 457 17073619 

  53. 53 Cho Y.K. Jung Y.S. Sung H. Sim M.K. Kim Y.K. High frequency of gross deletions in 5′ LTR/gag and nef genes in patients infected with CRF02_AG of HIV type 1 who survived for over 20 years: an association with Korean red ginseng AIDS Res Hum Retroviruses 25 2009 535 541 19388822 

  54. 54 Cho Y.K. Jung Y.S. Dosage and duration effects of Korean red ginseng intake on frequency of gross deletions in the nef gene J Ginseng Res 34 2010 219 226 

  55. 55 Cho Y.K. Jung Y.S. High frequency of gross deletions in the 5' LTR and gag regions in HIV type 1-infected long-term survivors treated with Korean red ginseng AIDS Res Hum Retroviruses 24 2008 181 193 18284321 

  56. 56 Cho Y.K. Jung Y. Sung H. Joo C.H. Frequent genetic defects in the HIV-1 5′ LTR/gag gene in hemophiliacs treated with Korean Red Ginseng: decreased detection of genetic defects by highly active antiretroviral therapy J Ginseng Res 35 2011 413 420 23717086 

  57. 57 Wang H.X. Ng T.B. Quinqueginsin, a novel protein with anti-human immunodeficiency virus, antifungal, ribonuclease and cell-free translation-inhibitory activities from American ginseng roots Biochem Biophys Res Commun 269 2000 203 208 10694500 

  58. 58 Lam S.K. Ng T.B. A xylanase from roots of sanchi ginseng (Panax notoginseng) with inhibitory effects on human immunodeficiency virus-1 reverse transcriptase Life Sci 70 2002 3049 3058 12138018 

  59. 59 Jeong J.J. Kim B. Kim D.H. Ginsenoside Rh1 eliminates the cytoprotective phenotype of human immunodeficiency virus type 1-transduced human macrophages by inhibiting the phosphorylation of pyruvate dehydrogenase lipoamide kinase isozyme 1 Biol Pharm Bull 36 2013 1088 1094 23811558 

  60. 60 Jeong J.J. Kim B. Kim D.H. Ginsenoside Rb1 eliminates HIV-1 (D3)-transduced cytoprotective human macrophages by inhibiting the AKT pathway J Med Food 17 2014 849 854 24983400 

  61. 61 Kim Y. Hollenbaugh J.A. Kim D.H. Kim B. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat PLoS One 6 2011 e21781 21765914 

  62. 62 Shi J. Cao B. Zha W.B. Wu X.L. Liu L.S. Xiao W.J. Gu R.R. Sun R.B. Yu X.Y. Zheng T. Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo Acta Pharmacol Sin 34 2013 1349 1358 23892274 

  63. 63 Lee L.S. Wise S.D. Chan C. Parsons T.L. Flexner C. Lietman P.S. Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius J Clin Pharmacol 48 2008 599 609 18319359 

  64. 64 Patel J. Buddha B. Dey S. Pal D. Mitra A.K. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity Am J Ther 11 2004 262 277 15266218 

  65. 65 Kukhanova M.K. Korovina A.N. Kochetkov S.N. Human herpes simplex virus: life cycle and development of inhibitors Biochemistry (Mosc) 79 2014 1635 1652 25749169 

  66. 66 McGeoch D.J. Cook S. Dolan A. Jamieson F.E. Telford E.A.R. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses J Mol Biol 247 1995 443 458 7714900 

  67. 67 Kimberlin D.W. Herpes simplex virus infections in neonates and early childhood Semin Pediatr Infect Dis 16 2005 271 281 16210107 

  68. 68 Gupta R. Warren T. Wald A. Genital herpes Lancet 370 2007 2127 2137 18156035 

  69. 69 Pei Y. Du Q. Liao P.Y. Chen Z.P. Wang D. Yang C.R. Kitazato K. Wang Y.F. Zhang Y.J. Notoginsenoside ST-4 inhibits virus penetration of herpes simplex virus in vitro J Asian Nat Prod Res 13 2011 498 504 21623512 

  70. 70 Liang Y.Y. Wang B. Qian D.M. Li L. Wang Z.H. Hu M. Song X.X. Inhibitory effects of Ginsenoside Rb1 on apoptosis caused by HSV-1 in human glioma cells Virol Sin 27 2012 19 25 22270803 

  71. 71 Cho A. Roh Y.S. Uyangaa E. Park S. Kim J.W. Lim K.H. Kwon J. Eo S.K. Lim C.W. Kim B. Protective effects of red ginseng extract against vaginal herpes simplex virus infection J Ginseng Res 37 2013 210 218 23717174 

  72. 72 Perfect M.M. Bourne N. Ebel C. Rosenthal S.L. Use of complementary and alternative medicine for the treatment of genital herpes Herpes 12 2005 38 41 16209859 

  73. 73 Lee M.H. Lee B.H. Lee S. Choi C. Reduction of hepatitis A virus on FRhK-4 cells treated with Korean red ginseng extract and ginsenosides J Food Sci 78 2013 M1412 M1415 23931146 

  74. 74 Kramvis A. Kew M. Francois G. Hepatitis B virus genotypes Vaccine 23 2005 2409 2423 15752827 

  75. 75 Zhang Y.Q. Guo J.S. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma World J Gastroenterol 21 2015 3860 3866 25852270 

  76. 76 Kang L.J. Choi Y.J. Lee S.G. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication Int J Biochem Cell Biol 45 2013 2612 2621 24004833 

  77. 77 Atmar R.L. Estes M.K. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses Clin Microbiol Rev 14 2001 15 37 11148001 

  78. 78 Moore M.D. Goulter R.M. Jaykus L.A. Human norovirus as a foodborne pathogen: challenges and developments Annu Rev Food Sci Technol 6 2015 411 433 25884284 

  79. 79 Bae J. Schwab K.J. Evaluation of murine norovirus, feline calicivirus, poliovirus, and MS2 as surrogates for human norovirus in a model of viral persistence in surface water and groundwater Appl Environ Microbiol 74 2008 477 484 18065626 

  80. 80 Lee M.H. Lee B.H. Jung J.Y. Cheon D.S. Kim K.T. Choi C. Antiviral effect of korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus J Ginseng Res 35 2011 429 435 23717088 

  81. 81 Lee M.H. Seo D.J. Kang J.H. Oh S.H. Choi C. Expression of antiviral cytokines in Crandell-Reese feline kidney cells pretreated with Korean red ginseng extract or ginsenosides Food Chem Toxicol 70 2014 19 25 24795234 

  82. 82 Bernstein D.I. Rotavirus overview Pediatr Infect Dis J 28 2009 S50 S53 19252423 

  83. 83 Parashar U.D. Gibson C.J. Bresse J.S. Glass R.I. Rotavirus and severe childhood diarrhea Emerg Inf Dis 12 2006 304 306 

  84. 84 Victora C.G. Bryce J. Fontaine O. Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy Bull World Health Organ 78 2000 1246 1255 11100619 

  85. 85 Lee J.H. Shim J.S. Lee J.S. Kim M.K. Chung M.S. Kim K.H. Pectin-like acidic polysaccharide from Panax ginseng with selective antiadhesive activity against pathogenic bacteria Carbohydr Res 341 2006 1154 1163 16643869 

  86. 86 Rabenau H.F. Richter M. Doerr H.W. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany Med Microbiol Immunol 199 2010 45 51 19941005 

  87. 87 Chan L.G. Parashar U.D. Lye M.S. Ong F.G. Zaki S.R. Alexander J.P. Ho K.K. Han L.L. Pallansch M.A. Suleiman A.B. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group Clin Infect Dis 31 2000 678 683 11017815 

  88. 88 Hamaguchi T. Fujisawa H. Sakai K. Okino S. Kurosaki N. Nishimura Y. Shimizu H. Yamada M. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult Emerg Infect Dis 14 2008 828 830 18439374 

  89. 89 Bruu A.L. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. A practical guide to clinical virology 2nd ed. 2003 Wiley NJ, United States 44 45 

  90. 90 Muir P. Kammerer U. Korn K. Mulders M.N. Poyry T. Weissbrich B. Kandolf R. Cleator G.M. van Loon A.M. Molecular typing of enteroviruses: current status and future requirements. The European Union concerted action on virus meningitis and encephalitis Clin Microbiol Rev 11 1998 202 227 9457433 

  91. 91 Gupta S. Markham D.W. Drazner M.H. Mammen P.P. Fulminant myocarditis Nat Clin Pract Cardiovasc Med 5 2008 693 706 18797433 

  92. 92 Tracy S. Gauntt C. Group B coxsackievirus virulence Curr Top Microbiol Immunol 323 2008 49 63 18357765 

  93. 93 Heim A. Grumbach I. Pring-Åkerblom P. Stille-Siegener M. Müller G. Kandolf R. Figulla H.-R. Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-α Antiviral Res 34 1997 101 111 9191017 

  94. 94 Wang X. Wang Y. Ren Z. Qian C. Li Y. Wang Q. Zhang Y. Zheng L. Jiang J. Yang C. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3 Pathobiology 79 2012 285 289 22688124 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로